REGENXBIO Ownership | Who Owns REGENXBIO?

Overview Forecast RevenueFinancials Chart Transcripts

REGENXBIO Ownership Summary

REGENXBIO is owned by 15.03% institutional investors, 7.78% insiders, and 77.19% retail investors. Blackrock is the largest institutional shareholder, holding 18.83% of RGNX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.94% of its assets in REGENXBIO shares.

RGNX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	REGENXBIO	15.03%	7.78%	77.19%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	8.61M	18.83%	$100.73M
Blackrock funding, inc. /de	5.78M	11.21%	$48.46M
Redmile group	4.37M	8.47%	$36.61M
Jpmorgan chase	3.48M	6.76%	$27.07M
Vanguard group	3.37M	6.53%	$48.59M
State street	2.73M	5.30%	$22.89M
Morgan stanley	2.07M	4.01%	$17.31M
Goldman sachs group	1.84M	3.57%	$15.41M
Integral health asset management	1.50M	2.91%	$12.57M
Qube research	1.31M	2.54%	$10.98M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sonic gp	453.08K	10.94%	$5.30M
Aquilo capital management	346.30K	4.04%	$2.68M
22nw, lp	492.76K	2.83%	$4.13M
Redmile group	4.37M	2.42%	$36.61M
Lion point capital, lp	26.60K	1.33%	$222.91K
Ghost tree capital	170.00K	0.62%	$1.99M
Integral health asset management	1.50M	0.60%	$12.57M
Act capital management	67.50K	0.53%	$808.65K
Napatree capital	49.76K	0.47%	$582.24K
Archpoint investors	222.28K	0.44%	$1.86M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	8.61M	0.00%	1.01M
Qube research	1.31M	0.01%	867.80K
Norges bank	449.40K	0.00%	449.40K
State street	2.73M	0.00%	444.75K
Invenomic capital management lp	426.90K	0.20%	426.90K

Top Sellers

Holder	Shares	% Assets	Change
Assenagon asset management	169.28K	0.00%	-811.33K
Avidity partners management lp	532.00K	0.40%	-600.56K
Aquilo capital management	346.30K	4.04%	-584.41K
Adage capital partners gp	-	-	-500.00K
22nw, lp	492.76K	2.83%	-430.92K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	449.40K	0.00%	449.40K	$3.47M
Invenomic capital management lp	426.90K	0.20%	426.90K	$4.12M
Vanguard fiduciary trust	312.06K	0.00%	312.06K	$2.62M
Prosight management, lp	200.00K	0.27%	200.00K	$1.68M
Nebula research & development	151.29K	0.11%	151.29K	$1.24M

Sold Out

Holder	Change
Tradewinds capital management	-3.00
Mendota financial group	-4.00
Smartleaf asset management	-5.00
Nelson, van denburg & campbell wealth management group	-8.00
Innealta capital	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	63	-65.76%	7,751,176	-81.16%	15	0.24%	33	-63.33%	17	-70.69%
Dec 31, 2025	125	-28.98%	29,932,803	-27.67%	57	0.90%	60	-28.57%	40	-23.08%
Sep 30, 2025	168	-	41,425,722	-1.46%	80	1.21%	77	-9.41%	51	4.08%
Jun 30, 2025	167	-1.18%	42,031,093	1.56%	81	1.26%	84	-2.33%	49	-5.77%
Mar 31, 2025	171	-6.04%	41,665,554	-0.97%	81	1.18%	87	-9.38%	54	8.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	2.94M	5.94%	-
State Street® SPDR® S&P® Biotech ETF	1.95M	3.78%	-43.44K
Vanguard Total Stock Mkt Idx Inv	1.50M	2.90%	68.10K
Vanguard US Total Market Shares ETF	1.40M	2.80%	-
iShares Russell 2000 ETF	1.28M	2.48%	7.59K
SPDR® S&P Biotech ETF	738.99K	1.46%	1.65K
Invesco S&P 500 ETF	731.22K	1.45%	731.22K
JPMorgan Small Cap Growth A	647.45K	1.25%	-492.55K
Nuveen Quant Small Cap Equity R6	630.21K	1.22%	-
Vanguard Small Cap Index	561.89K	1.13%	3.30K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 02, 2026	PAKOLA STEVE	Chief Medical Officer	Sell	$29.48K
Jun 29, 2026	PAKOLA STEVE	Chief Medical Officer	Sell	$216.47K
Jul 01, 2026	PAKOLA STEVE	Chief Medical Officer	Sell	$472.28K
May 11, 2026	PAKOLA STEVE	Chief Medical Officer	Sell	$168.71K
Mar 10, 2026	PAKOLA STEVE	Chief Medical Officer	Sell	$53.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	1
2026 Q2	-	2
2026 Q1	-	1
2025 Q4	-	1
2025 Q3	-	2

RGNX Ownership FAQ

Who Owns REGENXBIO?

REGENXBIO shareholders are primarily institutional investors at 15.03%, followed by 7.78% insiders and 77.19% retail investors. The average institutional ownership in REGENXBIO's industry, Biotech Stocks , is 35.43%, which REGENXBIO falls below.

Who owns the most shares of REGENXBIO?

REGENXBIO’s largest shareholders are Blackrock (8.61M shares, 18.83%), Blackrock funding, inc. /de (5.78M shares, 11.21%), and Redmile group (4.37M shares, 8.47%). Together, they hold 38.51% of REGENXBIO’s total shares outstanding.

Does Blackrock own REGENXBIO?

Yes, BlackRock owns 18.83% of REGENXBIO, totaling 8.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 100.73M$. In the last quarter, BlackRock increased its holdings by 1.01M shares, a 13.29% change.

Who is REGENXBIO’s biggest shareholder by percentage of total assets invested?

Sonic gp is REGENXBIO’s biggest shareholder by percentage of total assets invested, with 10.94% of its assets in 453.08K REGENXBIO shares, valued at 5.3M$.

Who is the top mutual fund holder of REGENXBIO shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of REGENXBIO shares, with 5.94% of its total shares outstanding invested in 2.94M REGENXBIO shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools